Dynamic alterations of dural and bone marrow B cells in an animal model of progressive multiple sclerosis

Alexandra Florescu1, Michelle Zuo1, Angela A Wang1

  • 1Department of Immunology, University of Toronto, Toronto, Canada.

PubMed

Insights

In multiple sclerosis (MS), immune cells in the brain's leptomeninges (LM) differ with age. Aged mice show more severe disease due to altered B cell populations in the brain and dura.

Area of Science:

  • Neuroimmunology
  • Immunology
  • Neurology

Background:

  • Immune cell aggregates in the leptomeninges (LM) are characteristic of multiple sclerosis (MS) and linked to disease progression.
  • The specific role and impact of LM inflammation on the adjacent dura mater in MS pathogenesis remain largely unexplored.

Purpose of the Study:

  • To investigate the impact of LM inflammation on the adjacent dura in a mouse model of MS.
  • To analyze the dynamic changes in B cell populations within the brain, LM, and dura in relation to age-dependent disease severity.

Main Methods:

  • Utilized a mouse model of MS exhibiting brain LM inflammation and age-dependent disease progression.
  • Analyzed immune cell infiltration, specifically T cells and B cell subsets (B220high and B220low), in the brain, LM, and dura.
  • Correlated B cell populations with disease onset, remission, and severity in young versus aged mice.

Main Results:

  • Encephalitogenic T cells and B220high B cells accumulated in the brain LM and parenchyma of both young and aged mice.
  • The dura remained relatively unaffected, but contained a distinct population of anti-CD20-resistant B220low B cells.
  • Aged mice exhibited a decrease in brain-resident B220low B cells and an increase in class-switched B220high B cells, correlating with severe, chronic disease.

Conclusions:

  • Dynamic alterations in B cell populations within the brain, LM, and dura are associated with age-dependent MS severity.
  • The balance between B220low and B220high B cells in the central nervous system compartments may influence disease progression and chronicity in MS.